Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.62 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | C1S | P09871 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | RXRB | P28702 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2172128 | 0.83 | TPMT (0.44) | TPMTHCAR1HPGDPARP1HCAR2 | |
| SCHEMBL9986680 | 0.79 | RXRA (0.50) | TPMTHCAR1ALDH1A1RXRARXRB | |
| SCHEMBL7937175 | 0.79 | TPMT (0.65) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL16305559 | 0.79 | TPMT (0.65) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL95695 | 0.77 | TPMT (0.62) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL221684 | 0.77 | TPMT (1.00) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL133987 | 0.77 | TPMT (0.62) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL6113105 | 0.74 | TPMT (0.59) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL347092 | 0.74 | TPMT (0.59) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL6113477 | 0.74 | TPMT (0.59) | TPMTHCAR1PRSS1PRSS2C1S |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116297-A1 | Use of polyprenol and its derivatives for facilitating growth of plants | KWON SEONG-RYONG (KR) | 2004-06-17 | — | — | US | claimed |
| US-10022454-B2 | Functionalized phosphorodiamites for therapeutic oligonucleotide synthesis | LIPOSCIENCES, LLC (US) | 2018-07-17 | — | — | US | disclosed |
| US-20170224832-A9 | SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE | PETERSEN SCOTT G (US) | 2017-08-10 | — | — | US | disclosed |
| EP-3067359-A1 | SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE | Petersen, Scott G. (US) | 2016-09-14 | — | — | EP | disclosed |
| US-8906279-B2 | Manufacturing method of polarizing plate protective film, polarizing plate protective film, polarizing plate, and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-20140329775-A1 | SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE | PETERSEN SCOTT G (US) | 2014-11-06 | — | — | US | disclosed |
| US-8569405-B2 | Additive mixtures for styrenic polymers | BASF SE (DE) | 2013-10-29 | — | — | US | disclosed |
| US-8518302-B2 | Stabilization of organic materials | BASF SE (DE) | 2013-08-27 | — | — | US | disclosed |
| US-8252862-B2 | Silane coupling agents for filled rubbers | BASF SE (DE) | 2012-08-28 | — | — | US | disclosed |
| US-20120142988-A1 | METHOD OF PRODUCING 1-HEXENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| US-5367008-A | 3-(alkoxyphenyl)benzofuran-2-ones as stabilisers | CIBA-GEIGY CORPORATION (US) | 1994-11-22 | — | — | US | disclosed |
| US-5356966-A | Stabilizing organic material against oxidative, thermal or light iinduced degradation | CIBA-GEIGY CORPORATION (US) | 1994-10-18 | — | — | US | disclosed |
| EP-0608198-A1 | Cyclic diphenylacetonenitriles as stabilisers | CIBA-GEIGY AG (CH) | 1994-07-27 | — | — | EP | disclosed |
| EP-0591102-A1 | 3-(2-Acyloxyethoxyphenyl)benzofuran-2-ones as stabilizers | CIBA-GEIGY AG (CH) | 1994-04-06 | — | — | EP | disclosed |
| EP-0589839-A1 | 3-(Dihydrobenzofuran-5-yl)benzofuran-2-ones as stabilizers | CIBA-GEIGY AG (CH) | 1994-03-30 | — | — | EP | disclosed |
| US-5077046-A | Plant extracts; mannaliam dolichols intermediates | KURARAY CO., LTD. (JP) | 1991-12-31 | — | — | US | disclosed |
| US-5012018-A | Extending polyisoprene chain using copper catalyst | KURARAY CO., LTD. (JP) | 1991-04-30 | — | — | US | disclosed |
| US-4886904-A | CONTAINING CIS AND TRANS ISOPRENE UNITS | KURARAY CO., LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| EP-0054753-B1 | POLYPRENYL COMPOSITION OR COMPOUNDS AND PROCESS FOR THE PRODUCTION THEREOF | KURARAY CO., LTD. (JP) | 1985-07-24 | — | — | EP | disclosed |
| EP-0054753-A1 | Polyprenyl composition or compounds and process for the production thereof | KURARAY CO., LTD. (JP) | 1982-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142988-A1 | METHOD OF PRODUCING 1-HEXENE | HRH1, HK1, HMOX1 | TPMT 1109/4885HCAR1 839/4885PRSS1 4231/4885 |
| US-20140329775-A1 | SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE | POLN, SARNP, NCL | TPMT 3886/4885HCAR1 4112/4885PRSS1 3049/4885 |
| US-10022454-B2 | Functionalized phosphorodiamites for therapeutic oligonucleotide synthesis | NCL, PHOSPHO1, POLN | TPMT 3047/4885HCAR1 4052/4885PRSS1 3802/4885 |
| US-20170224832-A9 | SELF DELIVERING BIO-LABILE PHOSPHATE PROTECTED PRO-OLIGOS FOR OLIGONUCLEOTIDE BASED THERAPEUTICS AND MEDIATING RNA INTERFERENCE | POLN, SARNP, NCL | TPMT 3886/4885HCAR1 4112/4885PRSS1 3049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.